Table 2.
Characteristics | Overall, n(%) | ALC | p-value | ||
---|---|---|---|---|---|
<1.8 | ≥1.8 | ||||
Chemotherapy | EC-T | 300(81.7) | 144 | 156 | 0.581 |
TCb | 41(11.2) | 18 | 23 | ||
P | 21(5.7) | 11 | 10 | ||
Others | 5(1.4) | 1 | 4 | ||
Radiation | Yes | 207(56.4) | 100 | 107 | 0.695 |
No | 160(43.6) | 74 | 86 | ||
Endocrine therapy | Yes | 160(43.6) | 77 | 83 | 0.810 |
No | 207(56.4) | 97 | 110 |
Abbreviations: EC-T, epirubicin and cyclophosphamide followed by docetaxel; TCb, docetaxel and carboplatin; P, paclitaxel; ALC, absolute lymphocyte count.